As a doctor-founded, doctor-led partnership organization, we’re focused on three dental surgical specialties – endodontics, oral surgery and periodontics. We provide efficient and effective back-office operational support across these specialties given their similarities while also ensuring we address the unique clinical aspects of each specialty.

Headquartered in Lewisville, Texas, BayMark Health Services is the largest provider of evidence-based opioid use disorder treatment services in North America. Company provides comprehensive treatment at different levels of care so that our medical providers and treatment staff are able to best meet the needs of the patients they serve.

Smile Doctors is a private equity sponsored (Linden Capital) dental support organization (DSO). Headquartered in Georgetown (TX) Smile Doctors is the largest orthodontic dental support organization with more than 200 affiliated practices in 19 states.Mr. D’Andria is a key business partner to the Chief Executive Officer and Board/Linden Capital Partners. He has the full and direct responsibility of all accounting and finance functions including audit, financial statement preparation, financial planning and analysis (analytics, budgeting, forecasting, Board level reporting), cash management and banking relations. In addition, manage companywide supply chain, property management, new construction, and leasing functions.

Maxor is a private equity sponsored (Beecken Petty O’Keefe and Company – BPOC.com), multisite national pharmacy services company that includes retail and mail order pharmacies, pharmacy benefit management, pharmacy consulting and management, home infusion, specialty pharmacy, third-party administration services, correctional pharmacy services, pharmacy audit, and pharmacy technology.As the Chief Financial Officer reporting to the CEO and the Board, he had the full and direct responsibility of all accounting and finance functions including audit, financial statement preparation, financial planning and analysis (analytics, pricing, budgeting, forecasting), cash management and banking relations. In addition, handled corporate wide purchasing ($273M drug purchases) and corporate secretary functions.

Managed three functional areas, including financial planning and analysis, investor relations, and mergers and acquisitions. Served as primary contact for investors. Participated in board-level audit committee meetings. Prepared as well as presented financial results and projections in regular board sessions. Personally led investor relations function as sole contact. Significantly improved financial forecasting processes and presentation of financial information to board. - Enabled company to achieve Earnings per Share (EPS) and profitability budget in 2014 for first time since 2012. Collaborated with leadership team around potential M&A opportunities and co-led finance due diligence during potential RSA Medical acquisition.- Restructured entire forecasting process, leading in company meeting internal financial targets in less than a year, as well as exceeding external financial guidance. - Led one-on-one meetings at investor conferences, supporting complex story through downturn in company’s history. - Increased number of buy ratings from six to eight on stock and recovered stock price from low of $16 per share (April 2014) to $23 per share (August 2014), a 44% improvement in market capitalization ($600,000,000). - Significantly improved the way company presented financial results to board of directors. - Received positive reviews from board members on quality of presentation, well -articulated analysis, and accuracy of forecast.

Held general manager responsibilities for $15,800,000 healthcare software and consulting business with 22% average annual growth. Managed reports of all key functions (product management, development, client services and implementation). Directed business unit since inception in 2009. Served in all key sales, including software-as-a-service product portfolio with episode of care reimbursement engine, leveraging PROMETHEUS Payment model, ACE, and IHA models, as well as additional products such as Medicare groupers, pricers, encoder, and medical necessity content. - Started B2B and payer technologies business unit, a start-up within company with legacy products. - Grew business from $9,500,000 to $15,800,000 in three years (22% average annual growth). - Created company’s first bundle payment reimbursement engine, a new and successful product category.

Set up processes for approval of new products and change in product strategy, monthly segment-level reporting process (monthly operational reports, BOD reports, and KPIs), segment-level resource allocation, and integration of existing and future acquisitions, as well as segment-level operational communication with executive team, marketing, and sales.- Led integration of Accuro, MDX, and XactiMed acquisitions, generating over $200,000,000 in revenue.- Executed on revenue and synergy opportunities, post-transaction.

Held responsibility for all corporate development activities and strategic planning for revenue cycle software business, including sourcing of deals, due diligence, valuation, letter of intent, negotiation of definitive agreement, closing, and integration planning. Prepared and presented 2009 operational plan.- Completed acquisition of Accuro ($350,000,000). Led integration of XactiMed, MD-X, and Accuro acquisitions. - Led the operational and strategic planning of acquired companies within a $200,000,000 business segment.

Built Financial Planning and Analysis (FP&A) Department and led company-wide implementation of Cognos Enterprise Planning software. Held responsibility for budgeting and forecasting for five subsidiaries, 750 employees and $230,000,000 revenue, as well as communicating financial projections to board members, internal and external stakeholders as lead presenter. - Led reverse due-diligence processes for two $75,000,000 acquisitions and $230,000,000 debt refinancing.- Directed FP&A department to never miss budget. - Built FP&A team that played critical role in prior IPO of company in December 2007.

Analyzed profitability metrics and executed initiatives in franchise and license division working closely with the president. Lead a 16 member due diligence team through a buy side transaction, analyzed current staffing industry and made recommendations to improve efficiency and new market penetration.

Performed various analyses including discounted cash flow, trading and transaction comparables for potential mergers and acquisitions. Interacted with CEOs and CFOs of public companies such as PPL corporation, El Paso, and Dominion during the execution of deals. Summarized valuations and effectively communicated results to managing directors. Coordinated comprehensive due diligence efforts; and performed research to identify current and emerging industry trends.

Designed and managed field activities for large construction projects such as MARTA, Candler Reservoir in Dunwoody, and $800 million hydroelectric power plant for Raytheon in Philippines

Managed team of 4 for field activities in 10 construction projects and provided technical assistance for Home Depot’s legal team in litigations involving contractors